NEOPLASMS, ENDOMETRIAL
Clinical trials for NEOPLASMS, ENDOMETRIAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, ENDOMETRIAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame advanced uterine cancer
Disease control Not yet recruitingThis study tests the safety of the immunotherapy drug dostarlimab when given together with standard chemotherapy (carboplatin and paclitaxel) as a first treatment for adults in India with advanced or recurrent endometrial cancer. Participants receive the drug combination initiall…
Matched conditions: NEOPLASMS, ENDOMETRIAL
Phase: PHASE4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for endometrial cancer: Mo-Rez drug faces chemo in major trial
Disease control Not yet recruitingThis large Phase 3 study tests a new drug called mocertatug rezetecan (Mo-Rez) against standard chemotherapy for people with endometrial cancer that has progressed after platinum-based chemo and immunotherapy. About 600 participants will be randomly assigned to receive either Mo-…
Matched conditions: NEOPLASMS, ENDOMETRIAL
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC